Nirrin Technologies is Biotechnology in United States that focus on life science business. Founded in 2018. They cover business area such as developer, real-time non-destructive bioprocess monitoring system, improved process control, fast process development, adaptive manufacturing, innovative chemometric method, application-specific knowledge, real-time analysis, glucose, lactate, VCD, TCD, protein, pharmaceutical company, medicine.
2018
( 6 years old in 2024 )
Life Science
-
44 Manning Road
Bellerica, MA 01821
United States
Private
developerreal-time non-destructive bioprocess monitoring systemimproved process controlfast process developmentadaptive manufacturinginnovative chemometric methodapplication-specific knowledgereal-time analysisglucoselactateVCDTCDproteinpharmaceutical companymedicine
* We use standard office opening hours in near Nirrin Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nirrin Technologies is Biotechnology business from United States that founded in 2018 (6 years old in 2024), Nirrin Technologies business is focusing on Life Science.
Nirrin Technologies headquarter office and corporate office address is located in 44 Manning Road Bellerica, MA 01821 United States.
Nirrin Technologies was founded in United States.
In 2024, Nirrin Technologies is currently focus on life science sector.
Above is snippet of Google Trends for "life science" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nirrin Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
